BDNF and cancer: Recent studies have linked axonogenesis to therapeutic resistance through neurotrophin-mediated nerve-cancer crosstalk, enhancing adaptive plasticity, stemness maintenance, and intratumoral sympathetic activation as a stress response to increase cell resistance [51–55].